The space launch market is tightening faster than suppliers can add capacity, and Rocket Lab is emerging as one of the most direct beneficiaries. With Amazon seeking an FCC extension for its satellite project—its factory churns out 30 units a week but can’t get them to orbit fast enough—the structural shortage of available rockets has become impossible to ignore. Clear Street analyst Greg Pendy seized on that dynamic this week, hiking his price target on Rocket Lab to $129, a call that briefly stood as the most ambitious on the Street before Stifel Nicolaus topped it with a fresh $132 target.
Stifel’s Erik Rasmussen, who raised his rating from $110, cited the company’s “consistent execution” and a growing defense book as catalysts. The stock responded by climbing roughly 3% in early trading, settling near $120, but the glow was short-lived. Four insiders—including President Marvin Clevenger, COO Frank Klein, and legal chief Arjun Kampani—unloaded shares worth a combined $18 million during the same week, some under pre-arranged trading plans. The selling triggered a slide of a magnitude not seen in over two years.
The insider exits come despite a near-flawless operational quarter. Rocket Lab recorded a record $200.3 million in revenue for Q1 2026, a 63.5% jump year-over-year, while GAAP gross margins hit an all-time high of 38.2%. The order backlog surged to $2.2 billion, up 20.2% from the prior quarter, and the company’s launch sales in Q1 alone already exceeded all of 2025. On the defense side, contracts with the Space Development Agency alone now top $1.3 billion, underpinning a shift toward more predictable, long-term revenue.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The real prize, however, remains the medium-lift Neutron rocket, whose first flight is scheduled for the fourth quarter of 2026. Q1 saw key technical milestones: first flight hardware integration, progress on Archimedes engine qualification, and development of the reusable second stage and payload fairing. A successful static-fire test in Q3 would be the next major positive signal. Stifel calls Neutron “the single most important valuation driver” over the long haul, but both analysts acknowledge the technical complexity—delays remain a realistic risk.
Analyst sentiment is split in a curious way. Every one of the 14 analysts tracked by Stifel rates the stock a buy. A broader survey of 18 analysts produces 9 buys, 4 holds, and an average price target of $103.91—well below the current trading level. The disconnect reflects the market’s struggle to price in the Neutron upside while also weighing near-term headwinds, including a cooling of sentiment around SpaceX’s blockbuster IPO. Elon Musk’s company is expected to debut on June 12 at a valuation of at least $1.8 trillion, an event that could lift the entire sector but also leaves some investors wary of frothy valuations.
Management sees Q2 revenue landing between $225 million and $240 million, above consensus, with non-GAAP gross margins of 38% to 40%. The Neutron launch in the final quarter of the year will be the ultimate test. If it succeeds, the debate over fair value will start all over again—and the current crop of record price targets may soon look conservative.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from June 5 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 5.
Rocket Lab USA: Buy or sell? Read more here...









